Eleison Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Eleison Pharmaceuticals LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10872
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Eleison Pharmaceuticals LLC (Eleison Pharmaceuticals) is a drug development company that acquires, develops, and commercializes clinical stage drug candidates for orphan cancers. The company’s pipeline products include glufosfamide and inhaled lipid-complexed cisplatin. Its glufosfamide is an analog of chemotherapeutic agent for treatment of metabolically active tumors and hypoxic tumor regions. Eleison Pharmaceuticals’ inhaled lipid-complexed cisplatin is a sustained release formulation of cisplatin in a nanoscale lipid based complex used for pediatric osteosarcoma – bone cancer. The company provides clinical trials for pancreatic cancer and osteosarcoma. Eleison Pharmaceuticals is headquartered in Princeton, New Jersey, the US.

Eleison Pharmaceuticals LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Eleison Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eleison Pharmaceuticals LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Eleison Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eleison Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Eleison Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Eleison Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Eleison Pharma Raises Funds Through Series B Venture Financing 10
Partnerships 11
Eleison Pharma Enters into Co-Development Agreement China Oncology Focus 11
Acquisition 12
Pharm-Olam Acquires Stake In Eleison Pharma For US$2 Million 12
Eleison Pharmaceuticals LLC – Key Competitors 13
Eleison Pharmaceuticals LLC – Key Employees 14
Eleison Pharmaceuticals LLC – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Eleison Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Key Facts 2
Eleison Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eleison Pharmaceuticals LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Eleison Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eleison Pharmaceuticals LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Eleison Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Eleison Pharma Raises Funds Through Series B Venture Financing 10
Eleison Pharma Enters into Co-Development Agreement China Oncology Focus 11
Pharm-Olam Acquires Stake In Eleison Pharma For US$2 Million 12
Eleison Pharmaceuticals LLC, Key Competitors 13
Eleison Pharmaceuticals LLC, Key Employees 14

List of Figures
Eleison Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Eleison Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Eleison Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Eleison Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Eleison Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eleison Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Eleison Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eleison Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Eleison Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Genor BioPharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Genor BioPharma Co Ltd (Genor) a subsidiary of Walvax Biotechnology Co Ltd is a bio-pharmaceutical company which develops and commercializes therapeutic monoclonal antibodies (mAbs), Fc-fusion proteins and recombinant therapeutic proteins. Its service offerings include process and assay deve …
  • iRhythm Technologies Inc (IRTC):医療機器:M&Aディール及び事業提携情報
    Summary iRhythm Technologies Inc (iRhythm) is a digital health care solutions company. It offers non-invasive long-term cardiac rhythm monitors. The company develops the Zio family of products and services to address the clinical needs of patients suffering from arrhythmias. Its product offerings in …
  • Western Sizzlin Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Western Sizzlin Corporation Mer …
  • Xbrane Biopharma AB (XBRANE):企業のM&A・提携動向(医療分野)
    Summary Xbrane Biopharma AB (Xbrane), formerly known as Xbrane Bioscience AB, is a biotechnology company that develops and manufactures complex generics. Its product portfolio includes biosimilars and generic drugs developed for people suffering from critical diseases. Xbrane combines its proprietar …
  • General Electric Company:企業の戦略・SWOT・財務分析
    SummaryGeneral Electric Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Ke …
  • Broadwind Energy, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Broadwind Energy, Inc. Mergers …
  • CEZ, AS:発電所・企業SWOT分析
    CEZ, AS - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives …
  • Polyplex Corporation Limited (POLYPLEX):企業概要、財務及び戦略的SWOT分析
    Summary Polyplex Corporation Limited (PCL) is a chemical company. The company manufactures thin polyester film in a wide range of thickness and surface properties covering a wide range of applications. It also offers BOPP film and CPP film. PCL offers a wide range of plastic film across several subs …
  • Lycera Corp:企業のM&A・提携動向(医療分野)
    Summary Lycera Corp (Lycera) is a biopharmaceutical company that develops therapies. The company discovers and develops small-molecule immunomodulators for the treatment of cancer and autoimmune diseases. Its pipeline products include LYC-30937-EC, RORy agonist, ROR antagonist, Rho kinase inhibitor, …
  • Stanford University-製薬・医療分野:企業M&A・提携分析
    Summary Stanford University is an educational and research organization that provides graduate and undergraduate programs. The organization’s services include education and research facilities. It provides research facilities through its research laboratories and centers. Stanford University include …
  • PAB Bankshares, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' PAB Bankshares, Inc. Mergers an …
  • LRAD Corporation:戦略・SWOT・企業財務分析
    LRAD Corporation - Strategy, SWOT and Corporate Finance Report Summary LRAD Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • EDP – Energias de Portugal, S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' EDP - Energias de Portugal, S.A …
  • Miltenyi Biotec GmbH:企業のM&A・提携動向(医療機器分野)
    Summary Miltenyi Biotec GmbH (Miltenyi) is a biotechnology company that provides biomedical research and cellular therapy products for cell isolation, flow cytometry, sample preparation and cell culture. The company's services include sample preparation, cell separation, flow cytometry, cell culture …
  • Western Gas Partners LP (WES):石油・ガス:M&Aディール及び事業提携情報
    Summary Western Gas Partners LP (Western Gas), a subsidiary of Anadarko Petroleum Corp is an oil and gas company that acquires, owns, develops and operates midstream energy assets. The company's services include processing, compressing, gathering, treating and transporting natural gas, natural gas l …
  • China Biologic Products Inc (CBPO):企業財務及び戦略的SWOT分析
    Summary China Biologic Products Inc (CBP) is a biopharmaceutical company that develops treatment products. The company manufactures, develops, and markets biologic products for the prevention and treatment of various diseases. Its plasma products include human albumin, human tetanus immunoglobulin, …
  • Edward Hospital & Health Services(製薬・医療分野):企業M&A動向
    Summary Edward Hospital & Health Services (EH & HS) is a healthcare service provider. The hospital provides medical specialties and various healthcare programs. It provides services such as, anxiety disorders, aortic aneurysm, aortic aneurysm screening (thoracic and abdominal), aortic stenosis, arrh …
  • Relief Therapeutics Holding AG (RLF):企業財務及び戦略的SWOT分析
    Summary Relief Therapeutics Holding AG (Relief Therapeutics) is a drug development company which focuses on the clinical development of peptides and proteins of natural or engineered origin. Its pipeline drug candidates include aviptadil for the treatment of sarcoidosis and low dose interleukin-6 (a …
  • Antares Pharma, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Antares Pharma, Inc. Mergers an …
  • KIYATEC Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary KIYATEC Inc (KIYATEC) is a biotechnology company that commercializes 3D cell culture technology. The company concentrates on data correlation to human clinical outcomes. It provides drug response profiling services for developing small molecule compounds and biologic drugs. KIYATEC offers cu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆